Telix Pharmaceuticals Limited Share Price
Equities
TLX
AU000000TLX2
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.080 AUD | -6.87% |
|
-10.28% | -18.93% |
| 03/02 | ASX Biggest Losers | MT |
| 03/02 | Telix Pharmaceuticals Chair Resigns | MT |
| Capitalization | 307.6Cr 218.18Cr 183.86Cr 167.8Cr 160.17Cr 297.43Cr 20TCr 1.95TCr 775.1Cr 9.52TCr 818.26Cr 801.48Cr 33TCr | P/E ratio 2025 * |
-1,324x | P/E ratio 2026 * | 1,395x |
|---|---|---|---|---|---|
| Enterprise value | 343.47Cr 243.63Cr 205.31Cr 187.37Cr 178.85Cr 332.11Cr 22TCr 2.18TCr 865.49Cr 11TCr 913.68Cr 894.95Cr 37TCr | EV / Sales 2025 |
3.17x | EV / Sales 2026 * | 2.55x |
| Free-Float |
58.65% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -6.87% | ||
| 1 week | -10.28% | ||
| Current month | -13.93% | ||
| 1 month | -19.22% | ||
| 3 months | -41.87% | ||
| 6 months | -46.24% | ||
| Current year | -18.93% |
| 1 week | 9.05 |  | 10.14 |
| 1 month | 9.05 | | 11.99 |
| Current year | 9.05 | | 11.99 |
| 1 year | 9.05 | | 31.97 |
| 3 years | 5.82 | | 31.97 |
| 5 years | 3.47 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.87% | -10.28% | -67.28% | +39.69% | 235.1Cr | |
| -1.74% | -3.90% | -16.81% | -8.62% | 4.61TCr | |
| -0.95% | +0.31% | +55.88% | +42.03% | 3.89TCr | |
| -0.42% | +11.19% | +38.03% | +60.37% | 3.62TCr | |
| -6.39% | -7.83% | -15.69% | -28.14% | 3TCr | |
| +0.31% | +2.41% | +134.45% | +285.55% | 1.89TCr | |
| -1.05% | -6.49% | +26.82% | -5.16% | 1.36TCr | |
| -0.61% | +0.84% | +73.78% | +92.48% | 1.36TCr | |
| -2.55% | -1.69% | +166.12% | +106.88% | 1.37TCr | |
| +9.84% | +18.04% | +29,974.70% | +3,916.49% | 1.32TCr | |
| Average | -0.98% | -2.05% | +3,037.00% | +450.16% | 2.27TCr | |
| Weighted average by Cap. | -1.09% | -1.62% | +1,784.87% | +275.74% |
| 2025 | 2026 * | |
|---|---|---|
| Net sales | 123.1Cr 87Cr 74Cr 67Cr 64Cr 119.04Cr 7.91TCr 780.08Cr 310.21Cr 3.81TCr 327.48Cr 320.76Cr 13TCr | 137.29Cr 97Cr 82Cr 75Cr 71Cr 132.75Cr 8.82TCr 869.98Cr 345.95Cr 4.25TCr 365.22Cr 357.73Cr 15TCr |
| Net income | 6L 4L 4L 3L 3L 6L 4.04Cr 39.87L 15.86L 1.95Cr 16.74L 16.39L 6.8Cr | 3.1Cr 2.2Cr 1.85Cr 1.69Cr 1.62Cr 3Cr 199.35Cr 20Cr 7.82Cr 96Cr 8.25Cr 8.08Cr 335.41Cr |
| Net Debt | 36Cr 25Cr 21Cr 20Cr 19Cr 35Cr 2.31TCr 227.31Cr 90Cr 1.11TCr 95Cr 93Cr 3.88TCr | 43Cr 31Cr 26Cr 24Cr 22Cr 42Cr 2.77TCr 273.45Cr 108.74Cr 1.34TCr 114.8Cr 112.44Cr 4.67TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | 9.080 $ | -6.87% | 32,65,810 |
| 11/26/11 | 9.750 $ | -3.08% | 20,94,567 |
| 10/26/10 | 10.06 $ | +2.03% | 22,74,148 |
| 09/26/09 | 9.860 $ | +0.10% | 26,93,647 |
| 06/26/06 | 9.850 $ | -2.76% | 30,02,322 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition